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Impact of restriction policy as part of an antimicrobial
stewardship program in a university hospital of a devel-
oping country
P. Titanti, V. Berdin˜as, J. Ramos, L. Manevich, L. Barcelona,
P. Rios, G. Lopardo ∗
Hospital B Houssay, Buenos Aires, Argentina
Background: In an era of growing concern about bacte-
rial resistance and hospital costs, limiting the use of broad
spectrum antibiotics is important. The purpose of this study
is to evaluate the impact of restriction policy as part of an
antimicrobial stewardship program.
Methods: The study was conducted in a 140-bed univer-
sity hospital of a developing country. Tools of the program
were development of guidelines of antimicrobial therapy
for common community and hospital-acquired infections and
education to improve antimicrobial prescription. During the
ﬁrst period of the program we implemented a policy of
prior approval for selected antibiotics. Every day pharma-
cists reviewed prescriptions and the team discussed with
prescribing physicians to accomplish with hospital guide-
lines. After one year of implementation of the program,
we stopped the restriction policy and we kept on working
with the other tools of the program. To assess if cessation
of restriction was associated with an increase in antimi-
crobial consumption, we measured antibiotic consumption
during the ﬁrst year (period 1) and during one year after
we stopped restriction (period 2). Antimicrobial consump-
tion was measured by Deﬁned Daily Dose (DDD) normalized
by 1000 bed-days.
Results: During the period 2 antibiotic consumption
of ceftriaxone, ceftazidime and vancomycin decreased;
it remained unchanged for piperacillin-tazobactam while
cefepime, imipenem and colsitin increased
Period 1 Period 2 Percentage
of Increase/
Decrease (%)
P value
Antibiotic DDD per
1000
beddays
Cefepime 53,73 80,97 +50,7 <0.01
Ceftazidime 17,56 12,57 -28,4 <0.01
Ceftriaxone 40,00 32,07 -19,8 <0,01
Colistin 9,25 19,50 +110,8 <0,01
Imipenem 14,11 21,65 +53,4 <0,01
Piperacillint-
azobactam
30,36 30,19 -0,05 0,9
Vancomycin 44,31 36,98 -16,5 <0,01
Conclusion: Antibiotic consumption of 4 out of 7 agents
did not increased after we stopped restriction policy, while
some agents suffered an increased; these agents were those
mainly prescribed in intensive care unit associated to an
increase in isolation of multidrug resistant Acinetobacter sp.
Programs aimed to improve antibiotic prescription accom-
panied by measurement of antibiotic consumption may help
to focus the program in some particular agents and areas of
the hospital, and also to reinforce other infection control
c
p
t
pts e199
easures.
oi:10.1016/j.ijid.2010.02.1928
0.003
tilization of activated protein C (Xigris) in a large teach-
ng hospital- Possible overuse and complications
.R. Wallace, C. Arinyedokiari ∗, B. Dattani
Orlando Health, Orlando, FL, USA
Background: The role of drotrecogin alpha (Xigris) in the
reatment of septic shock remains controversial. The recent
iterature suggests there is little or no beneﬁt, and deﬁnite
isk, for patients whose APACHE II scores are less than 25.
2007 Cochrane analysis stated that the beneﬁt of Xigris
n patients with higher APACHE II scores was supported only
y ‘‘very weak evidence’’. We reviewed our institutional
xperience with this agent.
Methods: Retrospective evaluation of the records of 73
atients receiving Xigris at an 808-bed teaching hospital
rom April 2003 to June 2008. APACHE II scores, demographic
ata, clinical outcomes, 28-day mortality, and incidence of
leeding complications were assessed.
Results: Forty-ﬁve of 73 (61%) patients had an APACHE
I score ≥25. The overall incidence of bleeding was 18 of
3 (25%); in 8 cases, severe or life-threatening bleeding
ccurred. Six of 18 (33%) patients with bleeding during the
nfusion had APACHE II scores < 25, with 4 of those 6 cases
escribed as severe. The 28-daymortality among all patients
as 25 of 73 (34%), with 19 of 25 (76%) having APACHE II
cores ≥25 and 6 of 25 (24%) having APACHE II scores < 25.
elative to the APACHE II scores, the 28-day mortality was
9 of 45(42%) among patients with an APACHE II score ≥25
nd 6 of 28 (21%) among patients with an APACHE II score <
5.
Conclusion: Thirty-nine percent of patients receiving
igris had APACHE II scores less than 25; its value in these
atients is unproven. The incidence of bleeding during infu-
ion of this drug is signiﬁcant and is associated with higher
PACHE II scores, but severe bleeding occurred even among
hose with lower APACHE II values, who were less likely to
erive any beneﬁt from its use. Xigris may be signiﬁcantly
ver utilized, and its use is not without risk.
oi:10.1016/j.ijid.2010.02.1929
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ntimicrobial prophylaxis for transrectal ultrasound
uided biopsy of prostate: a comparative study between
ingle dose of Gentamicin vs. Oﬂoxacin
. Chazan ∗, G. Zelichenko, Y. Shental, H. Edelstein, R. Raz
Ha Emek Medical Center, Afula, Israel
Background: Prostate cancer is the most common malig-
ancy in men, and has been increasing in incidence in the
estern world. The gold standard for diagnosing prostate
ancer is a transrectal US-guided biopsy. One of the com-
lications of this procedure is the development of urinary
ract infections. It has been shown that treatment with pro-
hylactic antibiotics prior to the procedure reduces the rate
